<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">888684</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2022.888684</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Herb Formula (GCis) Prevents Pulmonary Infection Secondary to Intracerebral Hemorrhage by Enhancing Peripheral Immunity and Intestinal Mucosal Immune Barrier</article-title>
<alt-title alt-title-type="left-running-head">Miao et al.</alt-title>
<alt-title alt-title-type="right-running-head">Immune and Pulmonary Infection</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Miao</surname>
<given-names>Yulu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1781437/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Bin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1386861/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1723516/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Hanyu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1446477/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Xiaojin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/572289/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Huang</surname>
<given-names>Yingying</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhuang</surname>
<given-names>Pengwei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/572286/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Yanjun</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/452740/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Chinese Materia Medica College</institution>, <institution>Tianjin University of Traditional Chinese Medicine</institution>, <addr-line>Tianjin</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>College of Pharmacy</institution>, <institution>Anhui University of Chinese Medicine and Anhui Academy of Chinese Medicine</institution>, <addr-line>Hefei</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Tianjin State Key Laboratory of Modern Chinese Medicine</institution>, <institution>Tianjin University of Traditional Chinese Medicine</institution>, <addr-line>Tianjin</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1137392/overview">Jian Gao</ext-link>, Shanghai Children&#x2019;s Medical Center, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/756568/overview">Yu-Ping Tang</ext-link>, Shaanxi University of Chinese Medicine, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/725711/overview">Min Jiang</ext-link>, Nankai University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yingying Huang, <email>huangyy9101@163.com</email>; Pengwei Zhuang, <email>zhuangpengwei@163.com</email>; Yanjun Zhang, <email>zyjsunye@163.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Inflammation Pharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>05</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>888684</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>03</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>04</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Miao, Wang, Hu, Zhang, Li, Huang, Zhuang and Zhang.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Miao, Wang, Hu, Zhang, Li, Huang, Zhuang and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Lung infection is a common complication induced by stroke and seriously affects the prognosis and life quality of patients. However, effective therapeutic strategies are still lacking. In the present study, the herb formula GCis was confirmed to prevent pulmonary infection induced by intracerebral hemorrhage (ICH). The animal model of lung infection induced by ICH, GCis (Ginseng Radix et Rhizoma, Aconiti Lateralis Radix Praeparata, and Cistanches Herba) was orally administrated every day for 7&#xa0;days. Lung microbial biomass and pathological results showed that the GCis formula pretreatment significantly reduced lung bacterial biomass and alleviated pathological abnormalities. These results indicated that the GCis formula has a clear pharmacological effect on preventing lung infection induced by ICH. Immunosuppression induced by ICH seemed to be the main mechanism of lung infection. Our results showed that the spleen and thymus indexes, WBC, and LY% contents were significantly increased in the GCis formula group. Moreover, bone marrow cells were further analyzed by transcriptome sequencing, and GO and KEGG enrichment analysis results showed that immune function was the main pathway enriched by differential genes after GCis formula intervention. More importantly, our results showed that GCis pretreatment had no significant effect on the mRNA expression of IL-1&#x3b2;, IL-6, and TNF-&#x3b1; in the brain. These results indicated that the GCis formula could enhance immunity after ICH. The intestinal barrier function was further investigated in the present study, considering the origin of the source of infection. Our results showed that the mRNA expressions of intestinal ZO-1, SIgA, and MUC2 were significantly increased, villi structure was intact, inflammatory cell infiltration was reduced, and goblet cell number was increased after GCis formula treatment. These results suggest that the GCis formula can enhance the intestinal mucosal immune barrier. This study provides a herb formula (GCis) that could enhance peripheral immunity and intestinal mucosal immune barrier to prevent pulmonary infection induced by ICH. It would be beneficial in the prevention of severe clinical infections.</p>
</abstract>
<kwd-group>
<kwd>intracerebral hemorrhage</kwd>
<kwd>immunosuppression</kwd>
<kwd>intestinal mucosal immune barrier</kwd>
<kwd>formula GCis</kwd>
<kwd>transcriptomics</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Stroke is a common central nervous system disease with a high disability rate and mortality, which can be divided into ischemic stroke and hemorrhagic stroke. ICH accounts for 10%&#x2013;17% of all strokes, and the mortality rate of patients is as high as 35%&#x2013;52% (<xref ref-type="bibr" rid="B11">Hazeldine and Lord, 2015</xref>; <xref ref-type="bibr" rid="B17">Kopp et al., 2017</xref>; <xref ref-type="bibr" rid="B18">Li and Liu, 2017</xref>). Lung infection is a common complication induced by ICH and seriously affects the prognosis and life quality of patients. The total infection rate of stroke-related infections (pneumonia and urinary tract infection) is 23%&#x2013;65%, and about 30% of deaths are related to them (<xref ref-type="bibr" rid="B32">Schaeffer, 2015</xref>; <xref ref-type="bibr" rid="B35">Shim, 2016</xref>). Therefore, poststroke infectious complications were reported to be a major reason for the readmission and death of stroke patients and associated with poor outcomes. Currently, antibiotics are still recommended as the clinical treatment of infection after ICH. Although the infection can be controlled, it is related to various side effects on the treatment and prognosis of the primary disease (<xref ref-type="bibr" rid="B33">Shi et al., 2018</xref>; <xref ref-type="bibr" rid="B21">Boning and Xiaojiaoyang, 2020</xref>). In addition, prophylactic use of antibiotics and &#x3b2;-blockers propranolol does not reduce the incidence of lung infection, and neurological function and prognosis do not improve (<xref ref-type="bibr" rid="B39">Westendorp et al., 2015</xref>). Hence, the development of a new drug is still very urgent and imperative for preventing lung infection induced by ICH.</p>
<p>The formulas of Traditional Chinese medicine (TCM), as an essential alternative and complementary medicine, have been widely utilized to recover the harmony disturbed in diseases through multi-target synergistic functions of its corresponding components (<xref ref-type="bibr" rid="B38">Wang et al., 2012</xref>; <xref ref-type="bibr" rid="B48">Zhang et al., 2015</xref>). Considerably, increasing clinical evidence demonstrates the desirable efficiency of the prescription of TCM in lung infection induced by ICH by alleviating the symptoms and improving lung function and quantity of life (<xref ref-type="bibr" rid="B10">Haifeng et al., 2015</xref>). GCis formula consists of three crude herbs, namely, Renshen (<italic>Ginseng Radix et Rhizoma</italic>), Fuzi (<italic>Aconiti Lateralis Radix Praeparata</italic>), and Rou Congrong (<italic>Cistanches Herba</italic>) in a specific ratio of 1:1:1. Ginseng invigorates the spleen and lungs, greatly invigorating the vitality; Aconite seed tonifies kidney Yang; Cistanche burns fire and helps Yang. This prescription is suitable for the stroke of Qi Xu, Fei Xu, and Qi Xue Liang Xu (<xref ref-type="bibr" rid="B46">Yu, 2016</xref>). However, the mechanisms of the TCM theory-based synthetic effects of Qi Xu, Fei Xu, and Qi Xue Liang Xu in GCis are not reported.</p>
<p>Clinical studies have found that patients with ICH injury showed impaired immune function, including a rapid and sustained decline of cellular immune function, spleen, thymus, and lymph node atrophy (<xref ref-type="bibr" rid="B29">Pr&#xfc;ss et al., 2017</xref>; <xref ref-type="bibr" rid="B40">Wong et al., 2017</xref>). In addition, there is a link between CNS, gut, and immune strictly, and regulated control of gut integrity is particularly important for host antibacterial immune defense (<xref ref-type="bibr" rid="B37">Stanley et al., 2018</xref>). In light of these, the regulation of immune function might be an effective modality to treat infection after ICH injury.</p>
<p>In the present work, with the animal model of lung infection induced by ICH, we assessed the lung bacterial biomass, and then the transcriptome of ileum and bone marrow were analyzed using RNA-Seq technology to elucidate the underlying mechanisms of GCis. Our study will highlight the synthetical prevention of lung infection induced by ICH superiority of the GCis formula and provide a foundation for future analyses of this and other TCM.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Extraction of GCis</title>
<p>GCis formulas were prepared with Renshen (White Ginseng), Fuzi (Hei Shunpian), and Rou Congrong combination (1:1:1). The herbs were acquired from Sinopharm Group Beijing Huamiao Pharmaceutical Co., Ltd. (Beijing, China). The combined extraction liquid was soaked with 10-time distilled water for 30&#xa0;min, then microboiled for 1&#xa0;h twice, and mixed with the twice filtrate. Finally, the mixture was concentrated and dried to produce the GCis.</p>
</sec>
<sec id="s2-2">
<title>Animal Experimental Design</title>
<p>Male C57BL/6J mice (7&#x2013;8&#xa0;weeks old, 20&#x2013;24&#xa0;g, Experimental Animal Center, Vital River Laboratory Animal Technology Co., Ltd., Beijing, China) were housed in cages with a temperature of 22 &#xb1; 2&#xb0;C and humidity of 40 &#xb1; 5%, under a 12&#xa0;h light/dark cycle. Standard mouse chow and water were provided ad libitum. The mice adapted for 7&#xa0;days and were randomly divided into four groups: Control, Model, GCis-L, and GCis-H (<italic>n</italic> &#x3d; 15 per group).</p>
<p>After the 7-day habituation period, except for mice in the control group, the collagenase IV-S (St. Louis, MO, United States) was performed on all animals to produce ICH models. Following intraperitoneal injection of 40&#xa0;mg/kg pentobarbital, mice were placed in a stereotaxic frame, shaved, and swabbed the incision area with 70% ethanol. A 30-gauge needle was inserted through a burr hole on the skull into the striatum (stereotaxic coordinates: 0.5&#xa0;mm anterior to the bregma, 2.3&#xa0;mm lateral to the midline, and 3.7&#xa0;mm below the skull). ICH was induced by microinfusion pump-mediated injection of 0.03U collagenase type IV-S in 0.5&#xa0;&#x3bc;L saline at a constant rate of 0.2&#xa0;&#x3bc;L/min. The needle was slowly removed after an additional 5&#xa0;min delay to prevent backflow. Body temperature was maintained at 37&#xb0;C with a rectal probe and a heating blanket until the mice woke up.</p>
<p>Three days before ICH surgery, the mice in treatment groups were intragastrically administered with GCis once daily for 3&#xa0;days: the GCis-L group received 1.3&#xa0;g/kg/d, the GCis-H group received 3.9&#xa0;g/kg/d, and the sham-operated and ICH model groups received distilled water <italic>via</italic> gavage at the dose of 10&#xa0;ml/kg. On the day of surgery and after the operation, the mice continue to receive drugs or distilled water for 7&#xa0;days.</p>
<p>On day 7, the mice were anesthetized intraperitoneally, the viscera (brain, lung, thymus, spleen, bone marrow, and ileum) were rapidly taken out and stored at a &#x2212;80&#xb0;C refrigerator, the viscera and body weights were calculated as an index of viscus, and brain edema was measured based on brain weight.</p>
</sec>
<sec id="s2-3">
<title>Neurobehavioral Tests</title>
<p>Examinations of neurological deficits of the experimental animals were performed 7&#xa0;days after surgery. The neurological function was blindly scored on the wire hang test, beam walking test, and elevated body swing test (EBST) as previously described (<xref ref-type="bibr" rid="B41">Wu et al., 2009</xref>). The wire hang and beam walking tests were graded from 0 to 5 (0, the worst; 5, the best). Greater scores indicated better neurological functions. EBST was calculated as the percentage of right-biased swings (R) in the total swings recorded (20 times, sum of left- and right-biased swings), R/(L &#x2b; R).</p>
</sec>
<sec id="s2-4">
<title>Measurement of ICH Area</title>
<p>Twenty-four hours after the last administration, mice were anesthetized and the brain tissue was harvested quickly except for the olfactory bulb, cerebellum, and lower brainstem. Afterward, the brain was dissected into coronal slices (2&#xa0;mm thick, <italic>n</italic> &#x3d; 6). Generally, the slices were digitized and analyzed with ImageJ software, and the hemorrhagic injury volume was presented as a percentage (%) of (total hematoma volume/total brain volume) &#xd7; 100.</p>
</sec>
<sec id="s2-5">
<title>Histological Examination</title>
<p>Lung and ileum tissue were harvested and fixed in 4% (v/v) buffered paraformaldehyde, then embedded in paraffin, sectioned at 4&#xa0;&#x3bc;m thickness, applied to glass slides, and stained with hematoxylin and eosin (H&#x26;E) solution. Afterward, the goblet cell was observed by Alcian blue/periodic acid-Schiff (AB/PAS) straining. HE and AB/PAS-stained images were acquired with an upright microscope in &#xd7;100 and &#xd7;200 magnification (Leica Microsystems, Wetzlar, Germany).</p>
</sec>
<sec id="s2-6">
<title>Quantification of Lung Biomass</title>
<p>By using the EasyPure<sup>&#xae;</sup> Genomic DNA Kit (Transgen, Beijing, China), total DNA was isolated from lung tissue. qPCR was conducted on samples to determine the relative amount of bacteria using published bacteria-specific primer sequences (<xref ref-type="bibr" rid="B35">Shim, 2016</xref>; <xref ref-type="bibr" rid="B2">Bronchard et al., 2004</xref>) for SYBR Green reagent (Bio-rad) on a CFX96Touch RT-PCR system (Bio-rad). The 16Sr RNA/Rpp30 value was calculated by the 2<sup>&#x2212;dCt</sup> method to indicate the bacterial load of lung tissue.</p>
</sec>
<sec id="s2-7">
<title>Assessment of Intestinal Permeability</title>
<p>The lactulose/mannitol (L/M) test is widely used to evaluate intestinal permeability in humans and animals, including mice. Animals fasted for 8&#xa0;h, gavaged with 0.5&#xa0;ml lactulose and mannitol mixture solution (containing 60&#xa0;mg/ml fructose and 40&#xa0;mg/ml mannitol), and housed in metabolic cages individually. Urine samples were collected after 12&#xa0;h. Lactulose and mannitol concentrations for each urine sample were quantified by UPLC/MS, as previously described (<xref ref-type="bibr" rid="B9">Gervasoni et al., 2018</xref>; <xref ref-type="bibr" rid="B43">Xu et al., 2015</xref>). Final data were presented as a ratio of lactulose and mannitol.</p>
</sec>
<sec id="s2-8">
<title>Measurement of SIgA in Intestinal Mucus</title>
<p>Intestinal mucus from the duodenum to terminal ileum was collected with a smooth pincette and transferred to an Eppendorf tube, homogenized in 0.5&#xa0;ml cold PBS, and then centrifuged at 4&#xb0;C at 3,000&#xa0;r/min for 10&#xa0;min. The supernatant was collected, and the content of SIgA was measured according to the manufacturer&#x2019;s protocol. Then, the protein content of the supernatant was determined by the BCA method. The SIgA level was expressed as nanograms per milligram of total protein.</p>
</sec>
<sec id="s2-9">
<title>UPLC-Q-TOF/MS Determination Content of Neurotransmitter</title>
<p>Ileum tissue samples were weighed to 30 mg, and 200&#xa0;&#x3bc;L water MP homogenate was added, followed by vortexing for 60&#xa0;s. Then, an 800&#xa0;&#x3bc;L methanol acetonitrile solution (1:1, V/V) was added, followed by vortexing for 60&#xa0;s , at low-temperature ultrasonic for 30&#xa0;min, twice. Precipitated protein was placed at &#x2212;20&#xb0;C for 1 h, 14,000&#xa0;rpm. Finally, after centrifuging at 4&#xb0;C for 20&#xa0;min, the supernatant was freeze-dried, and samples were stored at &#x2212;80&#xb0;C. While plasma samples were slowly dissolved at 4&#xb0;C, 100&#xa0;&#x3bc;L of each sample was taken, and 400&#xa0;&#x3bc;L of pre-cooled methanol acetonitrile solution (1:1, V/V) was added to the plasma samples, followed by vortexing for 60&#xa0;s, precipitation of protein, drying as above, and preservation of samples at &#x2212;80&#xb0;C.</p>
<p>Samples were analyzed by UPLC-Q-TOF/MS (Agilent 1290 Infinity LC/AB SCIEX). The peak area and retention time were extracted by Multiquant software, the retention time was corrected with neurotransmitter standard, and metabolites were identified. Information on all ion pairs of neurotransmitters is shown in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Information on all ion pairs of neurotransmitters.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Component name</th>
<th align="center">Analyte mass range</th>
<th align="center">Analyte retention time (min)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Acetylcholine</td>
<td align="char" char="/">146.1/60.1</td>
<td align="char" char=".">3.08</td>
</tr>
<tr>
<td align="left">Norepinephrine</td>
<td align="char" char="/">170.3/107.1</td>
<td align="char" char=".">7.96</td>
</tr>
<tr>
<td align="left">&#x3b3;-Amino-butyric acid</td>
<td align="char" char="/">104.0/87.1</td>
<td align="char" char=".">8.49</td>
</tr>
<tr>
<td align="left">Serotonin</td>
<td align="char" char="/">177.0/160.1</td>
<td align="char" char=".">5.92</td>
</tr>
<tr>
<td align="left">5-HIAA</td>
<td align="char" char="/">192.0/146.1</td>
<td align="char" char=".">1.27</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-10">
<title>RNA-Seq Sample Preparation and Analysis</title>
<p>Total RNA of ileum and bone marrow (<italic>n</italic> &#x3d; 5) were extracted using TRIzol<sup>&#xae;</sup> reagent (Invitrogen, Thermo Fisher Scientific Inc., USA). The integrity of the 28 and 18 s ribosomal RNA was determined on a 1% agarose gel to assess the degradation degree of RNA. While the concentration and purity of the isolated RNA were estimated by NanoDrop spectrophotometric measurements (ND-2000, NanoDrop, Thermo Fisher Scientific Inc.), the RNA integrity (RIN) was measured in the Agilent 2100 bioanalyzer (Agilent Technologies Inc., Germany). The RNA-Seq was performed at Applied Protein Technology (Shanghai, China). The directional cDNA libraries were prepared, the constructed library was qualified and quantified using the Qubit 2.0 fluorometer and the Agilent 2100 bioanalyzer, and the Illumina HiSeq platform was used for sequencing. The raw reads obtained from HiSeq sequencing are processed to obtain high-quality sequences (Clean Reads) by removing low-quality sequences and removing adaptor contamination. All subsequent analyses are based on Clean Reads. The gene expression level was measured in units of fragments per kilobase of transcript sequence per millions of base pairs sequenced (FPKM). <italic>p</italic>-value &#x3c;0.05 and &#x7c;log<sub>2</sub> foldchange&#x7c;&#x3e;1 were used for selecting differentially expressed genes (DEGs). The volcano plot and cluster heatmap were performed on the normalized gene expression data to visualize the resulting expression intensity values of the ileum transcripts (<xref ref-type="bibr" rid="B44">Xu et al., 2019</xref>).</p>
<p>In our study, the up-DEGs and down-DEGs in Mod <italic>vs</italic>. Sham and down- or upregulation in GCis <italic>vs</italic>. Mod were filtered out as reverse-regulated DEGs. The STRING tool (STRING; <ext-link ext-link-type="uri" xlink:href="https://string-db.org/">https://string-db.org/</ext-link>) was used to generate PPIs among the reverse-regulated DEGs. Then, Cytoscape was used to visualize the network. To explore gene function and regulatory networks of reverse-regulated DEGs, the enrichment analysis of Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathways mapping were conducted.</p>
</sec>
<sec id="s2-11">
<title>Quantitative Reverse Transcription-PCR</title>
<p>Brain, lung, and ileum tissues were homogenized in RNA lysis buffer. Total RNA was extracted using the Eastep total RNA extraction kit (Promega, Beijing). Equal amounts of RNA were reversely transcribed into cDNA with FastQuant RT kit (with gDNase) (Tiangen, Beijing) in accordance with the manufacturer&#x2019;s instructions. Relative gene expression was determined using specific quantitative primers (see <xref ref-type="table" rid="T1">Table 1</xref>). Polymerase chain reactions were performed on a CFX96 touch system (Bio-Rad, United States) with SuperReal PreMix Plus (SYBR Green) kit (Tiangen, Beijing). The mRNA expression levels were normalized to GAPDH using the <sup>&#x394;&#x394;</sup>Ct relative to control groups.</p>
</sec>
<sec id="s2-12">
<title>Statistical Analysis</title>
<p>For comparison of multiple groups, one-way analysis of variance (ANOVA) followed by the least-significant difference method was applied (GraphPad Prism 7 Software, Inc., La Jolla, CA, United States). <italic>p</italic>-value &#x3c; 0.05 was considered statistically significant. Data were analyzed by SPSS 22.0 software (International Business Machines Corp, Armonk, NY, United States, RRID: SCR_019096). The achieved data were expressed as the mean &#xb1; SEM.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>GCis Formula Pretreatment Ameliorated Pulmonary Infection Induced by ICH</title>
<sec id="s3-1-1">
<title>GCis Formula Decreased Area of ICH and Improved Neurological Function Scores</title>
<p>We observed a hematoma volume (<xref ref-type="fig" rid="F1">Figures 1A,B</xref>), and brain index (<xref ref-type="fig" rid="F1">Figure 1C</xref>) were significantly increased compared to the control group. In contrast, the hematoma volume was substantially ameliorated with GCis formula treatment (<italic>p</italic> &#x3c; 0.01) and the brain index of GCis formula showed no significant difference compared to the model group. Furthermore, as shown in <xref ref-type="fig" rid="F1">Figures 1D&#x2013;F</xref>, neurobehavioral tests also presented that GCis formula treatment markedly increased the neurological score of the wire hang test, beam walking test (<italic>p</italic> &#x3c; 0.05), and decreased the neurological score of EBST. A memorably higher level of IL-1&#x3b2; (<xref ref-type="fig" rid="F1">Figure 1G</xref>), IL-6 (<xref ref-type="fig" rid="F1">Figure 1H</xref>), and TNF-&#x3b1; (<xref ref-type="fig" rid="F1">Figure 1I</xref>) were observed in ICH mice (<italic>p</italic> &#x3c; 0.01), but no significance was observed with GCis formula treatment.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>GCis formula decreased area of ICH and improved neurological function scores. <bold>(A)</bold> Area of ICH. <bold>(B)</bold> hematoma volume of ICH, <bold>(C)</bold> brain index of ICH, <bold>(D)</bold> beam walking test, <bold>(E)</bold> wire hang test, <bold>(F)</bold> EBST, <bold>(G)</bold> IL-1&#x3b2;, <bold>(H)</bold> IL-6, and <bold>(I)</bold> TNF-a in the brain. Data are shown as mean &#xb1; SEM. &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01 compared with the sham group; <sup>&#x23;</sup>
<italic>p</italic> &#x3c; 0.05 and <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.01 compared with the model group.</p>
</caption>
<graphic xlink:href="fphar-13-888684-g001.tif"/>
</fig>
</sec>
<sec id="s3-1-2">
<title>GCis Formula Pretreatment Ameliorated Pulmonary Infection</title>
<p>16S/RPP30 was used to evaluate the relative content of intestinal flora in the lung tissue (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The relative content of intestinal flora was significantly increased compared with the control group. However, it was substantially ameliorated with GCis formula treatment (<italic>p</italic> &#x3c; 0.01). H&#x26;E staining was used to evaluate the inflammatory changes in the lung tissue. Extensive infiltration of inflammatory cells into peribronchial and perivascular regions was observed in ICH mice with significantly increased inflammatory scores, while they were significantly decreased with GCis treatment (<xref ref-type="fig" rid="F2">Figure 2B</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>GCis formula pretreatment ameliorated pulmonary infection. <bold>(A)</bold> Q-PCR 16S/RPP30 was measured by qRT-PCR. <bold>(B)</bold> Typical histological images of H&#x26;E-stained lung tissues (magnification &#xd7;100). Data are shown as mean &#xb1; SEM. &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01 compared with the SHAM group; <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.01 compared with the model group.</p>
</caption>
<graphic xlink:href="fphar-13-888684-g002.tif"/>
</fig>
</sec>
</sec>
<sec id="s3-2">
<title>GCis Formula Preconditioning Enhanced Peripheral Immunity in the Lung Infection Mice Induced by ICH</title>
<p>On day 7, the spleen, thymus index, white blood cell (WBC), and lymphocyte (LY%) were significantly reduced within the groups of the GCis formula in comparison with the control group (<italic>p</italic> &#x3c; 0.01) (<xref ref-type="fig" rid="F3">Figures 3A&#x2013;D</xref>). After 1&#xa0;week of treatments, the spleen, thymus index, and LY% of the GCis formula group (<italic>p</italic> &#x3c; 0.01) were significantly increased than the model group, suggesting that the GCis formula can improve the peripheral immunity in the lung infection mice induced by ICH.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>GCis formula preconditioning enhanced peripheral immunity in the lung infection mice. <bold>(A)</bold> Spleen index, <bold>(B)</bold> thymus index, <bold>(C)</bold> white blood cell, and <bold>(D)</bold> LY%. The upregulated (red) or downregulated (blue) genes <bold>(E)</bold>. <bold>(G)</bold> Sham group <italic>vs</italic>. model group <bold>(F)</bold>. <bold>(H)</bold> GCis group <italic>vs</italic>. model group. Bioinformatics analysis (GO and KEGG annotation) of 61 DEGs. <bold>(I)</bold> KEGG analysis of GCis 61 DEGs. <bold>(J)</bold> GO analysis of GCis 61 DEGs (data are shown as mean <bold>&#xb1;</bold> SEM. &#x2a;<italic>p</italic> &#x3c; 0.05 and &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01 compared with the sham group; <sup>&#x23;</sup>
<italic>p</italic> &#x3c; 0.05 and <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.01 compared with the model group).</p>
</caption>
<graphic xlink:href="fphar-13-888684-g003.tif"/>
</fig>
<p>DEGs were screened out by <italic>p</italic>-value &#x2264; 0.05 and &#x7c;log<sub>2</sub> foldchange&#x7c;&#x2265;1. The volcano plot showed the relative changes in gene levels (<xref ref-type="fig" rid="F3">Figures 3E,F</xref>). In the model <italic>vs</italic>. sham group, 855 DEGs were identified (552 upregulation and 303 downregulation). In the GCis formula <italic>vs</italic>. model group, 420 DEGs were identified (61 upregulation and 359 downregulation). A hierarchical cluster was used to obtain the sample clustering results (<xref ref-type="fig" rid="F3">Figures 3G,H</xref>). There were significant differences in gene expression between the model and sham groups, GCis and model group, and high similarity in gene expression between the same group.</p>
<p>Based on 61&#xa0;GCis formula DEGs, the GO and KEGG pathway enrichment was analyzed (<xref ref-type="fig" rid="F3">Figures 3I,J</xref>). The enriched pathways were mainly related to immune response, including synthesis and release of immune cells, B-cell-mediated immunity, lymphocyte-mediated immunity, adaptive immune response based on somatic recombination of immune, and Toll-like receptor signaling pathway.</p>
<sec id="s3-2-1">
<title>Validation of DEGs</title>
<p>QRT-PCR was executed to further validate the candidate DEGs containing H2-Q7, Cd209a, Ccr6, NF-&#x3ba;B1, PI3K, and CR2. As displayed in <xref ref-type="fig" rid="F4">Figure 4A</xref>, GCis formula treatment upregulated H2-Q7 significantly compared to the model group (<italic>p</italic> &#x3c; 0.01). <xref ref-type="fig" rid="F4">Figures 4B,C</xref> show that the GCis formula treatment downregulated Cd209a and Ccr6 significantly compared to the model group (<italic>p</italic> &#x3c; 0.01). As displayed in <xref ref-type="fig" rid="F4">Figure 4D</xref>, the GCis formula treatment showed no significance with NF-&#x3ba;B1 compared to the model group. <xref ref-type="fig" rid="F4">Figures 4E,F</xref> show that the GCis formula treatment downregulated PI3K and CR2 significantly compared to the model group (<italic>p</italic> &#x3c; 0.01).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Validation of H2-Q7 <bold>(A)</bold>, Cd209a <bold>(B)</bold>, Ccr6 <bold>(C)</bold>, NF-&#x3ba;B1<bold>(D)</bold>, PI3K <bold>(E)</bold>, and CR2 <bold>(F)</bold>. Data are shown as mean &#xb1; SEM. <italic>n</italic> &#x3d; 5, &#x2a;<italic>p</italic> &#x3c; 0.05 and &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01 compared with the sham group; <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.01 compared with the model group.</p>
</caption>
<graphic xlink:href="fphar-13-888684-g004.tif"/>
</fig>
</sec>
</sec>
<sec id="s3-3">
<title>GCis Formula Pretreatment Improved Intestinal Barrier Function in the Lung Infection Mice Induced by ICH</title>
<sec id="s3-3-1">
<title>GCis Formula Enhanced the Intestinal Barrier Function</title>
<p>In the model group, HE and AB-PAS staining of ileum tissue showed edema in the lamina propria and mucosal layer of the ileum compared with the sham group. Moreover, an obvious reduction of goblet cells in the mucosal layer was observed in the model group. Following the GCis formula, the edema in the lamina propria and the mucosal layer was significantly improved, and the goblet cells in the mucosal layer were increased (<xref ref-type="fig" rid="F5">Figures 5A,B</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>GCis formula enhanced the intestinal barrier function. HE <bold>(A)</bold> (magnification &#xd7;100) and AB-PAS <bold>(B)</bold> (magnification &#xd7;200) staining of ileum tissue. <bold>(C)</bold> Intestinal permeability was evaluated by L/M. MUC2 <bold>(D)</bold> and SlgA <bold>(E)</bold> were detected by ELISA. The expression of key indicators of the intestinal mucosal barrier occluding <bold>(F)</bold> and ZO-1 <bold>(G)</bold> (data are shown as mean &#xb1; SEM. &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01 compared with the sham group; <sup>&#x23;</sup>
<italic>p</italic> &#x3c; 0.05 compared with the model group).</p>
</caption>
<graphic xlink:href="fphar-13-888684-g005.tif"/>
</fig>
<p>L/M evaluated intestinal permeability in the ileum tissue of the ICH model mice. In this study, the expression levels of L/M in the ileum tissue were significantly higher in the model group than in the sham group (<italic>p</italic> &#x3c; 0.01). The GCis formula treatment significantly reduced the expression levels of L/M in the ileum tissue relative to the model group (<italic>p</italic> &#x3c; 0.05, <xref ref-type="fig" rid="F5">Figure 5C</xref>). MUC2 and SlgA were significantly lower in the model group than in the sham group (<italic>p</italic> &#x3c; 0.01) but higher than that of the model group following the GCis formula (<italic>p</italic> &#x3c; 0.01, <xref ref-type="fig" rid="F5">Figures 5D,E</xref>).</p>
<p>The expression of key indicators of the intestinal mucosal barrier (occludin and ZO-1) in ileum tissues was significantly lower in the model group than in the sham group (<italic>p</italic> &#x3c; 0.01). ZO-1 was significantly higher in the GCis formula group than in the model group (<italic>p</italic> &#x3c; 0.05), and occludin showed no significant difference in the GCis formula group and model group (<xref ref-type="fig" rid="F5">Figures 5F,G</xref>). These results indicate that the GCis formula improved the intestinal barrier function.</p>
</sec>
<sec id="s3-3-2">
<title>Transcriptome Analysis of DEGs</title>
<p>DEGs were screened out by <italic>p</italic>-value &#x2264; 0.05 and &#x7c;log<sub>2</sub> foldchange&#x7c;&#x2265;1. The volcano plot showed the relative changes in gene levels (<xref ref-type="fig" rid="F6">Figures 6A,B</xref>). Compared with the sham group, 1,281 differentially expressed genes were screened out in the model group, including 817 upregulated genes and 464 downregulated genes. A total of 555 differentially expressed genes were screened out between the GCis formula group and the model group, including 239 upregulated genes and 316 downregulated genes. The hierarchical cluster was used to obtain the sample clustering results (<xref ref-type="fig" rid="F6">Figures 6C,D</xref>). There were significant differences in gene expression between the model and sham groups and the GCis and model groups and high similarity in gene expression between the same groups.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Transcriptome analysis of DEGs in the ileum. The upregulated (red) or downregulated (blue) genes <bold>(A)</bold>. <bold>(C)</bold> Sham group <italic>vs</italic>. model group <bold>(B)</bold>. <bold>(D)</bold> GCis group <italic>vs</italic>. model group. Bioinformatics analysis (GO and KEGG annotation) of 228 DEGs. <bold>(E)</bold> GO analysis of GCis 228 DEGs. <bold>(F)</bold> KEGG analysis of GCis 228 DEGs.</p>
</caption>
<graphic xlink:href="fphar-13-888684-g006.tif"/>
</fig>
<p>We screened 228 differentially expressed genes after GCis formula intervention, including 66 upregulated genes and 162 downregulated genes. The GO and KEGG analyses were further performed on the differentially regulated genes so that the differentially expressed genes were significantly correlated with biological functions, biochemical metabolic pathways, and signal transduction pathways (<xref ref-type="fig" rid="F6">Figures 6E,F</xref>). Combined with the pathways enriched by regulated differential genes after GCis formula treatment, the two same pathways ranked first: chemokine signaling pathway, NF-&#x3ba;B signaling pathway, platelet activation, and amebiasis signaling pathway.</p>
</sec>
<sec id="s3-3-3">
<title>Validation of DEGs</title>
<p>To further verify the accuracy of sequencing results, qRT-PCR was used to detect the expression of genes in the intestinal barrier function-related pathways in ileum tissue. Compared with the sham group, the mRNA levels of Cxcr2, Cyp11b1, Gna14, Lcn2, Ccl17, and CFI in the model group were significantly upregulated (<italic>p</italic> &#x3c; 0.01). However, the mRNA levels of Hsd3b2, Mylk3, Calm1, and PLA were significantly downregulated (<italic>p</italic> &#x3c; 0.01, <xref ref-type="fig" rid="F7">Figures 7A&#x2013;J</xref>). Compared with the model group, the expression levels of Cxcr2, Cyp11b1, Gna14, Lcn2, Ccl17, and CFI mRNA in the GCis formula group were significantly downregulated (<italic>p</italic> &#x3c; 0.01 and <italic>p</italic> &#x3c; 0.05), and the expression levels of Hsd3b2 and Calm1 mRNA were upregulated (Calm1). In contrast, Mylk3 and PLA showed no significant difference after GCis formula treatment. Cxcr2, Ccl17, Lcn2, and other genes played important roles in regulating immune, inflammatory, and antimicrobial responses. PLA, Calm1, and Mylk3 are key targets of the platelet activation pathway and play significant roles in regulating inflammatory responses. These results indicate that the GCis formula may inhibit the expression of Cxcr2, Ccl17, and Lcn2; promote the expression of PLA, Calm1, and Mylk3; and participate in the regulation of chemokine signaling pathway, platelet activation, and amebiasis signaling pathway to improve the intestinal barrier function.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Validation of Cxcr2 <bold>(A)</bold>, Cyp11b1<bold>(B)</bold>, Gna14 <bold>(C)</bold>, Hsd3b2 <bold>(D)</bold>, Lcn2 <bold>(E)</bold>, Mylk3 <bold>(F)</bold>, Calm1 <bold>(G)</bold>, Ccl17 <bold>(H)</bold>, CFI <bold>(I)</bold>, PLA <bold>(J)</bold>, 5-HIAA <bold>(K)</bold>, acetylcholine <bold>(L)</bold>, norepinephrine <bold>(M)</bold>, NE/Ach <bold>(N)</bold>, &#x3b3;-amino-butyric acid <bold>(O)</bold>, serotonin <bold>(P)</bold>, and corticosterone <bold>(Q)</bold> (data are shown as mean &#xb1; SEM. &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01 compared with the sham group; <sup>&#x23;</sup>
<italic>p</italic> &#x3c; 0.05 and <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.01 and compared with the model group).</p>
</caption>
<graphic xlink:href="fphar-13-888684-g007.tif"/>
</fig>
<p>The hypothalamic-pituitary-adrenal (HPA) axis, sympathetic nervous system, and parasympathetic nervous system may cooperatively mediate immune function and intestinal barrier function after CNS injury (<xref ref-type="bibr" rid="B36">Stanley et al., 2016</xref>; <xref ref-type="bibr" rid="B29">Pr&#xfc;ss et al., 2017</xref>; <xref ref-type="bibr" rid="B47">Zhang et al., 2018</xref>). The pathways were mainly related to some neurotransmitters. Compared to the sham group, 5-hiAA (<xref ref-type="fig" rid="F7">Figure 7K</xref>), acetylcholine (<xref ref-type="fig" rid="F7">Figure 7L</xref>), Norepinephrine (<xref ref-type="fig" rid="F7">Figure 7M</xref>), gamma-amino-butyric acid (<xref ref-type="fig" rid="F7">Figure 7O</xref>), and serotonin (<xref ref-type="fig" rid="F7">Figure 7P</xref>) of model group were significantly decreased (<italic>p</italic> &#x3c; 0.01), while 5-HIAA and &#x3b3;-amino-butyric acid were significantly increased with GCis treatment (<italic>p</italic> &#x3c; 0.05). A memorably higher level of NE/Ach (<xref ref-type="fig" rid="F7">Figure 7N</xref>) and corticosterone (<xref ref-type="fig" rid="F7">Figure 7Q</xref>) were observed in the model group (<italic>p</italic> &#x3c; 0.01), while corticosterone was significantly decreased with the GCis treatment (<italic>p</italic> &#x3c; 0.01).</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Clinical and experimental studies have shown that lung infection is a common complication induced by stroke and seriously affects the prognosis and life quality of patients (<xref ref-type="bibr" rid="B5">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="B12">Hoffmann et al., 2017</xref>; <xref ref-type="bibr" rid="B16">Kigerl et al., 2018</xref>; <xref ref-type="bibr" rid="B30">Saand et al., 2019</xref>). Types of bacteria that have been commonly detected in the sputum and urine of stroke patients are common commensal bacteria that reside in the human intestinal tract (e.g., <italic>Enterococcus</italic> spp. and <italic>Escherichia coli</italic>). Peripheral immunosuppression and intestinal barrier dysfunction are key driving factors in its pathological progression (<xref ref-type="bibr" rid="B25">Mebius et al., 2005</xref>; <xref ref-type="bibr" rid="B4">Caso et al., 2016</xref>; <xref ref-type="bibr" rid="B23">Malone et al., 2019</xref>). For this, an effective and key means for lung infection is antimicrobial therapy (<xref ref-type="bibr" rid="B20">Lin et al., 2015</xref>; <xref ref-type="bibr" rid="B39">Westendorp et al., 2015</xref>). However, in clinical practice, effective therapeutic strategies are still urgent (Ma and Li., 2020). Therefore, in the present study, using collagenase IV-S-induced ICH mice, we attempted to demonstrate the therapeutic activities of the GCis formula, an extract from TCM including Renshen (White Ginseng), Fuzi (Hei Shunpian), and Rou Congrong combination (1:1:1). 16S/RPP30 and inflammatory changes in the lung tissue are common symptoms of lung infection. The results presented showed that the GCis formula prevented pulmonary infection induced by ICH, indicating a potential therapeutic capability for a lung infection, and had no effect on inflammatory factors in the brain.</p>
<p>In lung infection, inflammatory cytokines play prominent roles, while being important, which might be notably inhibited with GCis treatment. TNF-&#x3b1;, IL-6, and IL-1&#x3b2; induce an accumulation of inflammatory cells, provoking the generation of inflammatory mediators (<xref ref-type="bibr" rid="B22">Malaviya et al., 2017</xref>; <xref ref-type="bibr" rid="B34">Shibata et al., 2018</xref>). Mip-1&#x3b1; and MCP-1 are chemotactic cytokines that play an important role in promoting the circulation of effector cells to inflammatory sites (<xref ref-type="bibr" rid="B1">Brandenberger et al., 2018</xref>; <xref ref-type="bibr" rid="B45">Yang et al., 2020a</xref>). For these inflammatory mediators, GCis treatment memorably decreased their production in lung tissue of model mice, further strongly demonstrating its potential therapeutic property on lung infection.</p>
<p>Furthermore, potential mechanisms of the GCis formula on pulmonary infection induced by ICH were discussed here. Previously, it was found that peripheral immunity and intestinal mucosal immune barrier played critical roles in pulmonary infection (<xref ref-type="bibr" rid="B3">Camara-Lemarroy et al., 2014</xref>; <xref ref-type="bibr" rid="B14">Houlden et al., 2016</xref>).</p>
<p>Immunosuppression of IV-S-induced ICH mice mainly showed loss of lymphocyte, splenic contraction, and an increase in anti-inflammatory cytokine (<xref ref-type="bibr" rid="B28">Planas et al., 2012</xref>). The spleen, the largest secondary lymphoid organ, is the main reservoir of peripheral immune cells, combining innate and adaptive immune systems in a unique way (<xref ref-type="bibr" rid="B27">Pennypacker, 2014</xref>). Transcriptome focuses on the expression of functional genes and the molecular mechanism of biology, which has become a relatively mature research method in the field of biology. RNA-seq high-throughput sequencing technology has been successfully applied in studying various diseases, drugs, and biology. It can explain the functional characteristics of &#x201c;multi-component and multi-target&#x201d; TCM from the gene level, which is conducive to the modernization of TCM (<xref ref-type="bibr" rid="B43">Xu et al., 2016</xref>; <xref ref-type="bibr" rid="B19">Li et al., 2017</xref>). In this study, the results showed that the spleen and thymus index of the model group were all notably enhanced with the GCis treatment. Our transcriptomics data showed that GCis controlled 420 DEGs. Bioinformatics analysis suggested that the signaling pathways affected by GCis contained synthesis and release of immune cells, B-cell-mediated immunity, lymphocyte-mediated immunity, adaptive immune response based on somatic recombination of immune, and Toll-like receptor signaling pathway (<xref ref-type="bibr" rid="B8">Fu et al., 2015</xref>). H2-Q7, Cd209a, Ccr6, NF-&#x3ba;B1, PI3K, and CR2 are important targets that regulate immune, inflammatory, and antimicrobial responses (<xref ref-type="bibr" rid="B13">Hop et al., 2017</xref>).</p>
<p>Effective improvement of the intestinal barrier function is the key to alleviating pulmonary infection, such as intestinal permeability and intestinal mucosal immune (<xref ref-type="bibr" rid="B24">Manga et al., 2009</xref>; <xref ref-type="bibr" rid="B26">Metidji et al., 2018</xref>). Our present study also showed intestinal barrier injury, such as infiltration of lymphocytes and monocytes in the intestinal mucosal layer in ileum tissues, and a decrease in intestinal tight junction proteins (occludin and ZO-1) of the model mice (<xref ref-type="bibr" rid="B7">Crapser et al., 2017</xref>). GCis treatment significantly improved intestinal barrier injury. The results of ileum transcriptomics analysis showed that the GO and KEGG pathway enrichment of reversed genes after GCis formula intervention mainly included chemokine signaling pathway, NF-&#x3ba;B signaling pathway, platelet activation, and amebiasis signaling pathway. Cxcr2, Ccl17, and Lcn2 were the key targets that regulate the intestinal immune (<xref ref-type="bibr" rid="B15">Huang et al., 2016</xref>). PLA, Calm1, and Mylk3 are key targets of the platelet activation pathway and play significant roles in regulating inflammatory responses (<xref ref-type="bibr" rid="B42">Wu and Liu, 2012</xref>; <xref ref-type="bibr" rid="B6">Courties et al., 2019</xref>). Finally, we used molecular biotechnology to verify the credibility of quantitative transcriptomics by selected genes from DEGs, including Cxcr2, Cyp11b1, Gna14, Lcn2, Ccl17, CFI, Hsd3b2, Mylk3, Calm1, and PLA (<xref ref-type="bibr" rid="B13">Hop et al., 2017</xref>).</p>
<p>Our study has several limitations. First, the method of making ICH models or the choice of collagenase dosage may affect the animal&#x2019;s performance. We used a collagenase injection model and cannot rule out the possibility that the results would differ in other models of brain damage. Second, our study preliminarily evaluated the influence of stroke at different time points on immune function without a specific analysis of lymphocyte typing. However, it is a future line of investigation in the laboratory. Third, although we described a vital source of secondary infection poststroke, we did not establish bacterial translocation and dissemination after experimental induction of stroke, which will be addressed in a future study.</p>
<p>In conclusion, the presented study unveils the ameliorated effects of the GCis on pulmonary infection, suggesting its potential therapeutic usages in lung infection treatment partly through enhancing peripheral immunity and intestinal mucosal immune barrier. Nevertheless, because of the limited time and experimental conditions, some mechanisms were not explored. Immunoregulation has not been clearly proven. In addition to the foregoing limitations, compounds in the GCis have the complexity and diversity, and the exact effective components and whether they have pharmacodynamic synergy also need definition.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by the Ministry of Science and Technology of China&#x2019;s Guidance for the Care and Use of Laboratory Animals.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>The conception and design were proposed by YH, PZ, and YZ. Animal and molecular biology experiments were mainly performed by YM, HZ, and XL. Transcriptome analysis of DEGs and data analysis were performed by BW and JH. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s11">
<title>Funding</title>
<p>This work was supported by the Talent Support Program of Anhui University of Traditional Chinese Medicine (2020rcyb005), and Research Fund of Anhui University of Traditional Chinese Medicine (Natural Science Key Project) (2021zrzd10).</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>We thank the research team of the state key laboratory of component-based Chinese Medicine of Tianjin University of Traditional Chinese Medicine for their great support to this project.</p>
</ack>
<sec id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2022.888684/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2022.888684/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image1.TIF" id="SM1" mimetype="application/TIF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brandenberger</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kling</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Vital</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Christian</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The Role of Pulmonary and Systemic Immunosenescence in Acute Lung Injury</article-title>. <source>Aging Dis.</source> <volume>9</volume> (<issue>4</issue>), <fpage>553</fpage>&#x2013;<lpage>565</lpage>. <pub-id pub-id-type="doi">10.14336/AD.2017.0902</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bronchard</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Albaladejo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Brezac</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Geffroy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Seince</surname>
<given-names>P. F.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Early Onset Pneumonia</article-title>. <source>Anaesthesiol</source> <volume>100</volume> (<issue>2</issue>), <fpage>234</fpage>&#x2013;<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1097/00000542-200402000-00009</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camara-Lemarroy</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Ibarra-Yruegas</surname>
<given-names>B. E.</given-names>
</name>
<name>
<surname>Gongora-Rivera</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Gastrointestinal Complications after Ischemic Stroke</article-title>. <source>J. Neurol. Sci.</source> <volume>346</volume> (<issue>1-2</issue>), <fpage>20</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2014.08.027</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caso</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Balanz&#xe1;-Mart&#xed;nez</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Palomo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Bueno</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The Microbiota and Gut-Brain axis: Contributions to the Immunopathogenesis of Schizophrenia</article-title>. <source>Curr. Pharm. Des.</source> <volume>22</volume> (<issue>40</issue>), <fpage>6122</fpage>&#x2013;<lpage>6133</lpage>. <pub-id pub-id-type="doi">10.2174/1381612822666160906160911</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Venkat</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Seyfried</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chopp</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Brain-heart Interaction</article-title>. <source>Circ. Res.</source> <volume>121</volume> (<issue>4</issue>), <fpage>451</fpage>&#x2013;<lpage>468</lpage>. <pub-id pub-id-type="doi">10.1161/circresaha.117.311170</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Courties</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Frodermann</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Honold</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Herisson</surname>
<given-names>F. E.</given-names>
</name>
<name>
<surname>Schloss</surname>
<given-names>M. J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Glucocorticoids Regulate Bone Marrow B Lymphopoiesis after Stroke</article-title>. <source>Circ. Res.</source> <volume>124</volume> (<issue>9</issue>), <fpage>1372</fpage>&#x2013;<lpage>1385</lpage>. <pub-id pub-id-type="doi">10.1161/circresaha.118.314518</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crapser</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ritzel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Venna</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Koellhoffer</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Ischemic Stroke Induces Gut Permeability and Enhances Bacterial Translocation Leading to Sepsis in Aged Mice</article-title>. <source>Aging</source> <volume>8</volume> (<issue>5</issue>), <fpage>1049</fpage>&#x2013;<lpage>1063</lpage>. <pub-id pub-id-type="doi">10.18632/aging.100952</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Anrather</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>F. D.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Immune Interventions in Stroke</article-title>. <source>Nat. Rev. Neurol.</source> <volume>11</volume> (<issue>9</issue>), <fpage>524</fpage>&#x2013;<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2015.144</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gervasoni</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Primiano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Graziani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Scaldaferri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gasbarrini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Urbani</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Validation of UPLC-MS/MS Method for Determination of Urinary Lactulose/Mannitol</article-title>. <source>Molecules</source> <volume>23</volume> (<issue>10</issue>), <fpage>2705</fpage>. <pub-id pub-id-type="doi">10.3390/molecules23102705</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haifeng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hailong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jiansheng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xueqing</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Suyun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bin</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Effectiveness and Safety of Traditional Chinese Medicine on Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis</article-title>. <source>Complement. Ther. Med.</source> <volume>23</volume>, <fpage>603</fpage>&#x2013;<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1016/j.ctim.2015.06.015</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hazeldine</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lord</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Traumatic Brain Injury and Peripheral Immune Suppression: Primer and Prospectus</article-title>. <source>Front. Neurol.</source> <volume>6</volume>, <fpage>235</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2015.00235</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Harms</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ulm</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Nabiva</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Mackert</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Schemhl</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Stroke-induced Immunodepression and Dysphagia Independently Predict Stroke-Associated Pneumonia-The PREDICT Study</article-title>. <source>J. Cereb. Blood Flow. Metab.</source> <volume>37</volume> (<issue>12</issue>), <fpage>3671</fpage>&#x2013;<lpage>3682</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X16671964</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hop</surname>
<given-names>H. T.</given-names>
</name>
<name>
<surname>Arayan</surname>
<given-names>L. T.</given-names>
</name>
<name>
<surname>Huy</surname>
<given-names>T. X. N.</given-names>
</name>
<name>
<surname>Reyes</surname>
<given-names>A. W. B.</given-names>
</name>
<name>
<surname>Baek</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Lipocalin 2 (Lcn2) Interferes with Iron Uptake by Brucella Abortus and Dampens Immunoregulation during Infection of RAW 264.7 Macrophages</article-title>. <source>Cell. Microbiol.</source> <volume>20</volume> (<issue>3</issue>), <fpage>e12813</fpage>. <pub-id pub-id-type="doi">10.1111/cmi.12813</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houlden</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Goldrick</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brough</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vizi</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>L&#xe9;n&#xe1;rt</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Martinecz</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Brain Injury Induces Specific Changes in the Caecal Microbiota of Mice via Altered Autonomic Activity and Mucoprotein Production</article-title>. <source>Brain Behav. Immun.</source> <volume>57</volume>, <fpage>10</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2016.04.003</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>R. Y.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Meta-analysis of TCM Adjuvant Treatment for Stroke-Associated Pneumonia</article-title>. <source>J. Hunan. Univ. Chin. Med.</source> (<issue>1</issue>), <fpage>81</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1674-070X.2016.01.021</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kigerl</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Mostacada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Popovich</surname>
<given-names>P. G.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Gut Microbiota Are Disease-Modifying Factors after Traumatic Spinal Cord Injury</article-title>. <source>Neurotherapeutics</source> <volume>15</volume> (<issue>1</issue>), <fpage>60</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1007/s13311-017-0583-2</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kopp</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Watzlawick</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Martus</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Failli</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Finkenstaedt</surname>
<given-names>F. W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Long-term Functional Outcome in Patients with Acquired Infections after Acute Spinal Cord Injury</article-title>. <source>Neurol</source> <volume>88</volume> (<issue>9</issue>), <fpage>89</fpage>&#x2013;<lpage>900</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.0000000000003652</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C. Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Effect of Jianpi Yiqi Formula Combined with Acupuncture on Cerebral Apoplexy Complicated with Pneumonia</article-title>. <source>Shanxi. Tradit. Chin. Med.</source> (<issue>2</issue>), <fpage>201</fpage>&#x2013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1000-7369.2017.02.028</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Incidence of Constipation in Stroke Patients</article-title>. <source>Med</source> <volume>96</volume> (<issue>25</issue>), <fpage>e7225</fpage>. <pub-id pub-id-type="doi">10.1097/md.0000000000007225</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The Effects of Statins on Infections after Stroke or Transient Ischemic Attack: a Meta-Analysis</article-title>. <source>Plos. One.</source> <volume>10</volume> (<issue>7</issue>), <fpage>e130071</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0130071</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>B.-n.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.-j.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Resveratrol Extracted from Chinese Herbal Medicines: A Novel Therapeutic Strategy for Lung Diseases</article-title>. <source>Chin. Herbal Medicines</source> <volume>12</volume> (<issue>4</issue>), <fpage>349</fpage>&#x2013;<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1016/j.chmed.2020.07.003</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malaviya</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Laskin</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Laskin</surname>
<given-names>D. L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Anti-Tnf&#x3b1; Therapy in Inflammatory Lung Diseases</article-title>. <source>Pharmacol. Ther.</source> <volume>180</volume>, <fpage>90</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2017.06.008</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malone</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Amu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Waeber</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The Immune System and Stroke: from Current Targets to Future Therapy</article-title>. <source>Immunol. Cel. Biol.</source> <volume>97</volume> (<issue>1</issue>), <fpage>5</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1111/imcb.12191</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manga</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Schima</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Maier</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schober</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mueller-Mang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Comparison of Axial, Coronal, and Primary 3D Review in MDCT Colonography for the Detection of Small Polyps: A Phantom Study</article-title>. <source>Eur. J. Radiol.</source> <volume>70</volume> (<issue>1</issue>), <fpage>86</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejrad.2007.11.040</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mebius</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Kraal</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Eisenbarth</surname>
<given-names>S. C.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Structure and Function of the Spleen</article-title>. <source>Sci. Immunol.</source> <volume>5</volume> (<issue>8</issue>), <fpage>606</fpage>&#x2013;<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1126/sciimmunol.aau608510.1038/nri1669</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Metidji</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Omenetti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Crotta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nye</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>The Environmental Sensor AHR Protects from Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier Integrity</article-title>. <source>Immunity</source> <volume>49</volume> (<issue>2</issue>), <fpage>353</fpage>&#x2013;<lpage>362.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2018.07.010</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pennypacker</surname>
<given-names>K. R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Targeting the Peripheral Inflammatory Response to Stroke: Role of the Spleen</article-title>. <source>Transl. Stroke. Res.</source> <volume>5</volume> (<issue>6</issue>), <fpage>635</fpage>&#x2013;<lpage>637</lpage>. <pub-id pub-id-type="doi">10.1007/s12975-014-0372-8</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Planas</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>G&#xf3;mez-Choco</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Urra</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Urra</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gorina</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Caballero</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Brain-derived Antigens in Lymphoid Tissue of Patients with Acute Stroke</article-title>. <source>J. Immunol.</source> <volume>188</volume> (<issue>5</issue>), <fpage>2156</fpage>&#x2013;<lpage>2163</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1102289</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pr&#xfc;ss</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tedeschi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Thiriot</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Thiriot</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Loughhead</surname>
<given-names>S. M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Schwab Spinal Cord Injury-Induced Immunodeficiency Is Mediated by a Sympathetic-Neuroendocrine Adrenal Reflex</article-title>. <source>Nat. Neurosci.</source> <volume>20</volume> (<issue>11</issue>), <fpage>1549</fpage>&#x2013;<lpage>1559</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4643</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saand</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>S. H. Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Systemic Inflammation in Hemorrhagic Strokes-A Novel Neurological Sign and Therapeutic Target?</article-title> <source>J. Cereb. Blood Flow. Metab.</source> <volume>39</volume> (<issue>6</issue>), <fpage>959</fpage>&#x2013;<lpage>988</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X19841443</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaeffer</surname>
<given-names>E. M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The Preventive Antibiotics in Stroke Study (PASS): A Pragmatic Randomised Open-Label Masked Endpoint Clinical Trial</article-title>. <source>J. Urol.</source> <volume>195</volume> (<issue>2</issue>), <fpage>369</fpage>. <pub-id pub-id-type="doi">10.1016/j.juro.2015.10.039</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>F. D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Stroke-induced Immunosuppression and Poststroke Infection</article-title>. <source>Stroke Vasc. Neurol.</source> <volume>3</volume> (<issue>1</issue>), <fpage>34</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1136/svn-2017-000123</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shibata</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tateishi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamanishi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Miyazaki</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Basophils Trigger Emphysema Development in a Murine Model of COPD through IL-4-mediated Generation of MMP-12-Producing Macrophages. Proc</article-title>. <source>Natl. Acad. Sci. USA.</source> <volume>115</volume>, <fpage>13057</fpage>&#x2013;<lpage>13062</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1813927115</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shim</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Ischemia, Immunosuppression and Infection-Tackling the Predicaments of Post-Stroke Complications</article-title>. <source>Int.J.Mol.Sci.</source> <volume>17</volume> (<issue>1</issue>), <fpage>64</fpage>. <pub-id pub-id-type="doi">10.3390/ijms17010064</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanley</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Mackin</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Srikhanta</surname>
<given-names>Y. N.</given-names>
</name>
<name>
<surname>Lyras</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Prakash</surname>
<given-names>M. D.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Translocation and Dissemination of Commensal Bacteria in post-stroke Infection</article-title>. <source>Nat. Med.</source> <volume>22</volume> (<issue>11</issue>), <fpage>1277</fpage>&#x2013;<lpage>1284</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4194</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanley</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>C. H. Y.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>An Insight into Intestinal Mucosal Microbiota Disruption after Stroke</article-title>. <source>Sci. Rep.</source> <volume>8</volume> (<issue>1</issue>), <fpage>568</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-18904-8</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Meta-analysis of the Clinical Effectiveness of Traditional Chinese Medicine Formula Chaihu-Shugan-San in Depression</article-title>. <source>J. Ethnopharmacol.</source> <volume>141</volume>, <fpage>571</fpage>&#x2013;<lpage>577</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2011.08.079</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Westendorp</surname>
<given-names>W. F.</given-names>
</name>
<name>
<surname>Vermeij</surname>
<given-names>J.-D.</given-names>
</name>
<name>
<surname>Zock</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hooijenga</surname>
<given-names>I. J.</given-names>
</name>
<name>
<surname>Kruyt</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Bosboom</surname>
<given-names>H. J. L. W.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>The Preventive Antibiotics in Stroke Study (PASS): a Pragmatic Randomised Open-Label Masked Endpoint Clinical Trial</article-title>. <source>Lancet</source> <volume>385</volume> (<issue>9977</issue>), <fpage>1519</fpage>&#x2013;<lpage>1526</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(14)62456-9</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>C. H. Y.</given-names>
</name>
<name>
<surname>Jenne</surname>
<given-names>C. N.</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>P. P.</given-names>
</name>
<name>
<surname>L&#xe9;ger</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ryckborst</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Venegas</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Prolonged Activation of Invariant Natural Killer T Cells and T H 2-Skewed Immunity in Stroke Patients</article-title>. <source>Front. Neurol.</source> <volume>8</volume>, <fpage>6</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2017.00006</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Khatibi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sozen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Ac-YVAD-CMK Decreases Blood-Brain Barrier Degradation by Inhibiting Caspase-1 Activation of Interleukin-1&#x3b2; in Intracerebral Hemorrhage Mouse Model</article-title>. <source>Transl. Stroke. Res.</source> <volume>1</volume> (<issue>1</issue>), <fpage>57</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1007/s12975-009-0002-z</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X. X.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Clinical Thinking of Treating Stroke-Associated Pneumonia from Lung and Spleen</article-title>. <source>Tianjin. Tradit. Chin. Med.</source> <volume>29</volume> (<issue>6</issue>), <fpage>559</fpage>&#x2013;<lpage>561</lpage>. <comment>CNKI:SUN:TJZY.0.2012-06-015</comment>. <pub-id pub-id-type="doi">10.1007/s10330-012-1048-z</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Blockage of Protease-Activated Receptor 1 Ameliorates Heat-Stress Induced Intestinal High Permeability and Bacterial Translocation</article-title>. <source>Cell. Biol. Int.</source> <volume>39</volume> (<issue>4</issue>), <fpage>411</fpage>&#x2013;<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1002/cbin.10408</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Y. T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Integrated Chemical and Transcriptomic Analyses Unveils Synthetic Characteristics of Different Medicinal Root Parts of Angelica Sinensis</article-title>. <source>Chin. Herb. Med.</source> <volume>12</volume> (<issue>1</issue>), <fpage>19</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.chmed.2019.07.003</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020a</year>). <article-title>Multiple Components Rapidly Screened from Perilla Leaves Attenuate Asthma Airway Inflammation by Synergistic Targeting on Syk</article-title>. <source>J. Inflamm. Res.</source> <volume>13</volume>, <fpage>897</fpage>&#x2013;<lpage>911</lpage>. <pub-id pub-id-type="doi">10.2147/JIR.S281310.2147/JIR.S281393</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>L. Y.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Pharmacological Action and Clinical Application of Cistanche Deserticola</article-title>. <source>Inner. Mongolia. Tradit. Chin. Med.</source> <volume>35</volume> (<issue>4</issue>), <fpage>87</fpage>&#x2013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1006-0979.2016.04.086</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z. G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Organ-and Cell-specific Immune Responses Are Associated with the Outcomes of Intracerebral Hemorrhage</article-title>. <source>FASEB. J.</source> <volume>32</volume> (<issue>1</issue>), <fpage>220</fpage>&#x2013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201700324R</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B. L.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Efficacy-oriented Compatibility for Component-Based Chinese Medicine</article-title>. <source>Acta Pharmacol. Sin.</source> <volume>36</volume>, <fpage>654</fpage>&#x2013;<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1038/aps.2015.8</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>